NUCLEOCYTOPLASMIC TRANSPORT OF THE REV PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS DEPENDENT ON THE ACTIVATION DOMAIN OF THE PROTEIN

被引:58
|
作者
WOLFF, B
COHEN, G
HAUBER, J
MESHCHERYAKOVA, D
RABECK, C
机构
[1] Sandoz Research Institute, A-1235 Vienna
关键词
D O I
10.1006/excr.1995.1060
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The human immunodeficiency virus type 1 (HIV-1) regulatory protein Rev, which is required for the cytoplasmic expression of unspliced and incompletely spliced viral mRNAs, is located predominantly in the nucleolus. In this study, we show that Rev translocates from the nucleolus to the cytoplasm in HeLa and COS cells transfected with Rev under conditions where rRNA synthesis is inhibited (e.g., with actinomycin D). Dominant-negative mutants with mutations in the activation domain of Rev, which are known to inhibit wildtype Rev function in trans, are unable to leave the nucleus upon actinomycin D treatment. More importantly, when present in excess, these mutants inhibit the translocation of wild-type Rev. This correlation of inhibitory activities suggests that Rev function depends on its transport to and presence (at least transient) in the cytoplasm. In this context, we discuss the possibility that Rev is actively involved in the transport of HIV-1-specific mRNAs containing the Rev response element (a highly structured RNA sequence, which is specifically recognized by the Rev trans-activator). We also discuss the potential of nucleocytoplasmic export of Rev as a target for anti-HIV chemotherapy. (C) 1995 Academic Press, Inc.
引用
收藏
页码:31 / 41
页数:11
相关论文
共 50 条
  • [31] INTEGRATION IS NOT NECESSARY FOR EXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEIN PRODUCTS
    STEVENSON, M
    HAGGERTY, S
    LAMONICA, CA
    MEIER, CM
    WELCH, SK
    WASIAK, AJ
    JOURNAL OF VIROLOGY, 1990, 64 (05) : 2421 - 2425
  • [32] OLIGOMERIZATION OF THE NEF PROTEIN FROM HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1
    KIENZLE, N
    FREUND, J
    KALBITZER, HR
    MUELLERLANTZSCH, N
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 214 (02): : 451 - 457
  • [33] SUBCELLULAR-LOCALIZATION OF THE VIF PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    GONCALVES, J
    JALLEPALLI, P
    GABUZDA, DH
    JOURNAL OF VIROLOGY, 1994, 68 (02) : 704 - 712
  • [34] GENETIC-ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE PROTEIN
    SHIN, CG
    TADDEO, B
    HASELTINE, WA
    FARNET, CM
    JOURNAL OF VIROLOGY, 1994, 68 (03) : 1633 - 1642
  • [35] ACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY OXIDATIVE STRESS
    LEGRANDPOELS, S
    VAIRA, D
    PINCEMAIL, J
    VANDEVORST, A
    PIETTE, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (12) : 1389 - 1397
  • [36] THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VPU PROTEIN - A POTENTIAL REGULATOR OF PROTEOLYSIS AND PROTEIN-TRANSPORT IN THE MAMMALIAN SECRETORY PATHWAY
    VINCENT, MJ
    JABBAR, MA
    VIROLOGY, 1995, 213 (02) : 639 - 649
  • [37] EUKARYOTIC INITIATION FACTOR-5A IS A CELLULAR TARGET OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REV ACTIVATION DOMAIN MEDIATING TRANSACTIVATION
    RUHL, M
    HIMMELSPACH, M
    BAHR, GM
    HAMMERSCHMID, F
    JAKSCHE, H
    WOLFF, B
    ASCHAUER, H
    FARRINGTON, GK
    PROBST, H
    BEVEC, D
    HAUBER, J
    JOURNAL OF CELL BIOLOGY, 1993, 123 (06): : 1309 - 1320
  • [38] THE CENTRAL GLOBULAR DOMAIN OF THE NUCLEOCAPSID PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS CRITICAL FOR VIRION STRUCTURE AND INFECTIVITY
    OTTMANN, M
    GABUS, C
    DARLIX, JL
    JOURNAL OF VIROLOGY, 1995, 69 (03) : 1778 - 1784
  • [39] CELL-DEPENDENT REQUIREMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF PROTEIN FOR MATURATION OF VIRUS-PARTICLES
    SAKAI, H
    SHIBATA, R
    SAKURAGI, J
    SAKURAGI, S
    KAWAMURA, M
    ADACHI, A
    JOURNAL OF VIROLOGY, 1993, 67 (03) : 1663 - 1666
  • [40] FUNCTIONAL-ANALYSIS OF THE N-TERMINAL DOMAIN OF TAT PROTEIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    REDDY, MVR
    DESAI, M
    JEYAPAUL, J
    PRASAD, DDK
    SESHAMMA, T
    PALMERI, D
    KHAN, SA
    ONCOGENE, 1992, 7 (09) : 1743 - 1748